When we hear about SARS-CoV-2 immunity we mostly think: antibodies. These proteins are made by a group of immune cells, called B cells. Antibodies find and bind to foreign proteins in our bodies. They lock onto their targets, they signal other immune cells to come and clean up the infection. But less is known of the key role of T cells – the cousins of B cells – in immunity.
where TCRs are engineered to float through tissues without being bound to a cell, like antibodies do. The advantage here is that they are still able to recognise the whole spectrum of epitopes that T cells can see but which antibodies cannot do.) This technology is already being explored in cancer therapy.
Here is the current state of science on a Sparrho pinboard. NB: The pinboard contains research papers that have not been peer-reviewed yet, meaning that they have not gone through the standard scientific validation process yet.
Do you want to stay updated with the latest Covid-19 research? Sign up to our newsletter >>